Protein kinase C pathway is involved in the inhibition by crocetin of vascular smooth muscle cells proliferation

Phytotherapy Research

Volumn 24, Issue 11, 2010, Pages 1680-1686

  Zhou, Cheng Hua ^a   Xiang, Min ^b   He, Shu Ying ^c   Qian, Zhi Yu ^c  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Suzhou Health College   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

C fos; C jun; C myc; Crocetin; Protein kinase C

Indexed keywords

ANGIOTENSIN II; CHELERYTHRINE; CROCETIN; MYC PROTEIN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE C ALPHA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; COW; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE EXPRESSION; NONHUMAN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; CAROTENOIDS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; GARDENIA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE C;

BOVINAE; GARDENIA;

EID: 78049446056     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3194     Document Type: Article

References (25)

1. Azzi A, Boscoboinik D, Hensey C. 1992. The protein kinase C family. Eur J Biochem 208: 547-557.
2. 2+ on the activation of conventional and new PKC isozymes and on TPA and endothelin-1 induced translocations of these isozymes in intact cells. FEBS Lett 348: 21-26.
3. Fukumoto S, Nishizawa Y, Hosoi M et al. 1997. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 272: 13816-13822.
4. Ha KS, Exton JH. 1993. Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J Biol Chem 268: 10534-10539.
5. Han O, Takei T, Basson, M, Sumpio BE. 2001. Translocation of PKC isoforms in bovine aortic smooth muscle cells exposed to strain. J Cell Biochem 80: 367-372.
6. Herbert JM, Augereau JM, Gleye J, Maffrand JP. 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999.
7. Huleihel R, Yanai J. 2006. Disruption of the development of cholinergic-induced translocation/activation of PKC isoforms after prenatal heroin exposure. Brain Res Bull 69: 174-181.
8. Itoh H, Yamamura S, Ware JA et al. 2001. Differential effects of protein kinase C on human vascular smooth muscle cell proliferation and migration. Am J Physiol Heart Circ Physiol 281: H359-H370.
9. Leszczynski D, Joenvaara S, Foegh ML. 1996. Protein kinase C-alpha regulates proliferation but not apoptosis in rat coronary vascular smooth muscle cells. Life Sci 58: 599-606.
10. Muller DW. 1997. The role of proto-oncogenes in coronary restenosis. Prog Cardiovasc Dis 40: 117-128.
11. Renault-Mihara F, Beuvon F, Iturrioz X et al. 2006. Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell 17: 5141-5152.
12. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
13. Signorelli P, Luberto C, Hannun YA. 2001. Ceramide inhibition of NF-kappaB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl-terminal phosphorylation of PKC for the ceramide response. FASEB J 15: 2401-2414.
14. Skaletz-Rorowski A, Eschert H, Leng J et al. 2005. PKC delta-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells. Cardiovasc Res 67: 142-150.
15. Suh HW, Choi SS, Lee JK, Lee HK, Han EJ, Lee J. 2004. Regulation of c-fos and c-jun gene expression by lipopolysaccharide and cytokines in primary cultured astrocytes: effect of PKA and PKC pathways. Arch Pharm Res 27: 396-401.
16. Trilivas I, McDonough PM, Brown JH. 1991. Dissociation of protein kinase C redistribution from the phosphorylation of its substrates. J Biol Chem 266: 8431-8438.
17. Wang CJ, Cheng TC, Liu JY, Chou FP, Kuo ML, Lin JK. 1996. Inhibition of protein kinase C and proto-oncogene expression by crocetin in NIH/3T3 cells. Mol Carcinog 17: 235-240.
18. Wang Y, Yan T, Wang Q et al. 2008. PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on angiotensin II-induced proliferation of vascular smooth muscle cells. Biochem Biophys Res Commun 375: 151-155.
19. Xi L, Qian Z, Shen X, Wen N, Zhang Y. 2005. Crocetin prevents dexamethasone-induced insulin resistance in rats. Planta Med 71: 917-922.
20. Xie Z, Singh M, Siwik DA, Joyner WL, Singh K. 2003. Osteopontin inhibits interleukin-1beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta. J Biol Chem 278: 48546-48552.
21. Yamamoto M, Acevedo-Duncan M, Chalfant CE, Patel NA, Watson JE, Cooper DR. 2000. Acute glucose-induced downregulation of PKC-betaII accelerates cultured VSMC proliferation. Am J Physiol Cell Physiol 279: C587-C595.
22. Yano K, Bauchat JR, Liimatta MB, Clemmons DR, Duan C. 1999. Down-regulation of protein kinase C inhibits insulin-like growth factor I-induced vascular smooth muscle cell proliferation, migration, and gene expression. Endocrinology 140: 4622-4632.
23. 2+-dependent PKC APL I in the induction of intermediate-term facilitation. J Neurosci 26: 8847-8856.
24. Zhou CH, Qian ZY, Xiang M, He SY. 2007. Involvement of Ca(2+) in the inhibition by crocetin of angiotensin II-induced ERK1/2 activation in vascular smooth muscle cells. Eur J Pharmacol 554: 85-91.
25. Zhou CH, Qian ZY, Zheng SG, Xiang M. 2006. ERK1/2 pathway is involved in the inhibitory effect of crocetin on angiotensin II-induced vascular smooth muscle cell proliferation. Eur J Pharmacol 535: 61-68.